Approved comparison material connected to this topic.
11 total recordsSource comparisons are presented without a generated winner.
| Attribute | Melanotan 1 (No Hyphen) | Melanotan-1 (Hyphen) | Professional Assessment ||—|—|—|| Chemical Structure | [Nle4, D-Phe7]-α-MSH, 13 amino acids, cyclic disulfide bond | [Nle4, D-Phe7]-α-MSH, 13 amin…
The table below contrasts the two most-researched melanocortin peptide analogs. Despite similar names, their receptor profiles and clinical applications diverge significantly. Amino Acid Structure 13-residue l…
Published melanotan-II studies used protocol-defined dosing and monitoring, which is different from personal use of unapproved products [2], [7]. Study doses should not be interpreted as personal dosing advice…
When researchers are deciding which compound is right for their study, it's crucial to understand the nuances between the available options. The choice between Melanotan 1, Melanotan 2, and PT-141 often comes …
Amino Acid Sequence 13-amino-acid linear analog of α-MSH 7-amino-acid cyclic lactam bridge structure Melanotan-1's longer sequence confers greater MC1R selectivity Receptor Specificity High MC1R selectivity, m…
MC1R (Melanocytes) Melanogenesis (pigmentation) Upregulates tyrosinase via cAMP elevation Skin darkening without UV exposure This is the intended pharmacological target. Produces cosmetic tanning outcome MC3R …
Understanding where Melanotan 1 fits within the melanocortin peptide family requires direct comparison across receptor binding profiles, half-life, and adverse event patterns observed in research models. Alpha…
Receptor Selectivity Highly selective for MC1R Non-selective: binds MC1R, MC3R, MC4R, MC5R Melanotan-1 produces pigmentation with minimal off-target effects; melanotan-2's broader activity drives appetite and …
The table below contrasts Melanotan II with its close analog Melanotan I (afamelanotide), UV-induced tanning, and topical dihydroxyacetone (DHA) self-tanners across mechanism, receptor selectivity, photoprotec…
Melanotan 1 (afamelanotide, marketed as Scenesse for erythropoietic protoporphyria) and Melanotan 2 share the same core melanocortin pharmacophore. The His-Phe-Arg-Trp tetrapeptide sequence required for recept…
The original research justification for Melanotan II development was photoprotection—the hypothesis that pharmacologically induced melanin would shield keratinocyte DNA from UV damage the same way naturally ac…